bioharvest.com (BHST) Company Sales Revenue

bioharvest.com - graphic logo of issuer BHST

BioHarvest Sciences maintains high margins based on unique biofabrication patents, despite strict FDA oversight. The company's consolidated sales clearly demonstrate revenue dynamics, where the current figure stands at 0.03. While development is complicated by competition with chemical behemoths, expansion into the B2B nutraceutical and cosmetics segments ensures steady growth of the customer base.

BHST - BioHarvest Sciences Revenue and Sales Volume over the range 11/13/2024 - 11/15/2026

Comprehensive metric breakdowns and analytics for BioHarvest (BHST)

- market price and analyst price targets:
Summary company analysis:BHST, bioharvest.com
Original product of BioHarvest Sciences, Inc.

BioHarvest Sciences (BHST) effectively monetizes sustainable plant cell cultivation, reducing costs through ESG technologies. These operational successes translate into a daily influx of liquidity, shaping the dynamics of incoming cash flows. This metric captures daily sales volume, allowing for the identification of local price floors. Investors should evaluate this indicator as a capital movement vector rather than a static value. Analyzing the company's commercial revenue helps avoid value traps.

Analysis of competing companies

HLN: Company Sales Revenue|Company Revenue Kenvue (KVUE)|VRNA (Verona Pharma Corp) - Company Sales Revenue|Company Revenue Jyong Biotech MENS|Ligand Pharma - Company Revenue|AMRX - Company Revenue|Company Total Revenue perrigo.com|ALVO (Alvotech SA) - Company Sales|Company Total Sales Volume Liquidia Technologies LQDA|GLPG (Galapagos N.V.) - Revenue and Sales Volume|ANIP: Company Sales Revenue|Company Revenue Afrezza (MNKD)|Revenue and Sales Volume amphastar.com (AMPH)|Revenue and Sales Volume PCRX (pacira.com)|Company Sales Revenue SPRY|Theravance Biopharma Inc - Revenue and Sales Volume|Company Gross Revenue Aquestive Therapeutics AQST|SCPH: Revenue and Sales Volume|Company Sales Tectonic Therapeutic, Inc.|TNXP (tonixpharma.com) - Revenue and Sales Volume|SXTC (China SXT Pharmaceuticals, Inc.) - Company Total Sales|Company Revenue eupraxiapharma.com (EPRX)|Company Gross Revenue Invizyne|Company Revenue Oramed Pharmaceuticals ORMP|Company Sales Revenue ENTX|HYFT - Company Revenue|Company Sales Revenue ABVC (ABVC BioPharma Inc.)|CPIX: Revenue and Sales Volume|Quantum BioPharma Limited - Company Sales Revenue|FGEN (FibroGen Corp) - Revenue and Sales Volume|Revenue and Sales Volume Telomir Pharmaceuticals|Revenue and Sales Volume RANI|SNYR (Synergy CHC Corp.) - Company Sales Revenue|Revenue and Sales Volume RLYB (Rallybio Corp)|LEXX: Company Sales Volume|PULM - Company Revenue|PTHL: Company Revenue|APM (aptorumgroup.com) - Company Sales|Lyra Therapeutics - Company Sales Revenue|Company Revenue Impact BioMedical Inc|TNF Pharmaceuticals, Inc. (TNFA) - Company Gross Revenue|Revenue and Sales Volume YCBD|PRFX: Company Annual Revenue|Company Revenue altamiratherapeutics.com CYTO|Revenue and Sales Volume Lipella Pharmaceuticals Inc LIPO|OPTN - Company Revenue|Company Gross Revenue Pieris Pharma PIRS|Procaps Group SA (PROC) - Company Revenue|Company Annual Revenue PTPI (Petros Pharmaceuticals, Inc.)|QLI (Qilian International Holding) - Revenue and Sales Volume|SLRN: Company Sales Revenue|Revenue and Sales Volume TFFP